Cancer Research ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | Last week, we launched the £400m More Research, Less Cancer campaign calling on donors and philanthropists to support transformative cancer research.
And in support of this, a coalition of over 50 scientists signed a ‘letter to the world’, which highlights how we are at a pivotal moment in time for cancer research and why we need philanthropic support now more than ever.
The money raised by the campaign will enable more innovative research and translation and will support scientists at every stage of their careers.
Thank you to each and every member of our research community who has helped us to get to this point. You can continue to support the campaign by sharing it with your networks, or directly supporting our philanthropic activity – whether that be featuring in our communications, or meeting with philanthropic supporters when the opportunity arises.
Kind Regards,
Iain Foulkes
Executive Director Research & Innovation
CEO Cancer Research Horizons |
| | |
| | |
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
Well done to our Population and Prevention grant awardees |
| Meet the latest grant awardees selected by our Population and Prevention Research Committee:
Mark Hamer, Emmanuel Stamatakis, Rubeta Matin, Laura Woods, Linda Sharp and Rosalind Eeles received Project Awards. Christopher Bunce and Mark Drayson were selected for a Programme Award.
James Reading, Sam Janes, Seth Coffelt, Joanne Edwards, Stephanie May, Sanne van Neervan, Benjamin Simons, Emma Allott, Yi Feng, Matthew Rose-Zerilli, Matthew Ford and James Brenton received Biology to Prevention Awards. |
| | |
|
|
|
| | Understanding metastasis in the light of evolution |
| | “Despite being the most common cause of cancer-related mortality, metastasis is poorly understood.” Simone Zaccaria, Group Leader at the UCL Cancer Institute, talks about how his single-cell DNA sequencing technology could offer a new way to better understand metastasis and, more specifically, which cancer cells seed metastases, where they disseminate, and when they start.
Utilising samples from patients enrolled in the TRACERx and PEACE studies, Simone’s research group is bringing together multi-disciplinary expertise to enhance our understanding of cancer evolution and translate this for patient benefit. |
| | |
|
|
|---|
|
|
|
|
|
| | | | Iain Foulkes reflects on data sharing in a recent blog post.
Tech advances have led to research projects generating large amounts of data, making collaboration with commercial partners, who can bring in advanced analytics, more and more crucial to maximising their benefit for patients. However, patients can be reluctant to agree to their data being used by commercial organisations and with practical constraints on data sharing, the research community still lacks digital connectivity.
Iain argues that patient involvement in data partnerships is essential, and touches on our Guiding Principles for Data Partnerships, developed in close collaboration with patient advocates which we use to ensure that all partnerships involving patient-derived data have clear benefits for people affected by cancer, are without unacceptable risk, and represent emerging best practice. | | |
| | | | | | The International Rare Cancers Initiative is hosting a webinar on 12 March at 8–9 PM (GMT), on the role of artificial intelligence in cancer diagnosis and its potential to predict biomarkers, prognosis and therapeutic responses in precision medicine.
Clare Scott (Walter and Eliza Hall Institute of Medical Research), will chair an expert panel discussion on the technical challenges specific to rare cancers and adaptive techniques in scenarios where labelling is challenging, and input data is limited. Sarah Fremond (Leiden University Medical Centre) will explore AI's applicability in addressing rarer subgroups of patients.
| | |
|
|---|
|
|
|
|
Let’s talk about being a researcher with a long-term condition |
| Join this lunchtime webinar hosted by the Cancer Research UK Cambridge Centre which will explore the challenges and barriers faced by these researchers, and delve into how the research system can work towards being anti-ableist and support those who may otherwise find it difficult to pursue a long and fulfilling career.
It will kick off with a keynote presentation from Hamied Haroon, Research Associate at the University of Manchester and Co-Chair of the National Association of Disabled Staff Networks. This will be followed by a panel Q&A with colleagues based across the network of CRUK Centres including, Martin Bushell, Pippa Bark-Williams and Jessica Taylor.
|
| | |
|
|
|
What did you think of this email? |
|
| | |
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | You are playing a crucial role in helping us beat cancer sooner, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
